3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Classical hematology
1
Conditions
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Waldenstrom Macroglobulinemia
1
Thrombocytopenia
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Hodgkin Disease
1
Hand-Foot Syndrome
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
eltrombopag
9
avatrombopag
6
Platelet Transfusion
6
romiplostim
4
Tranexamic Acid
3
Radiotherapy
3
Cytarabine
3
oprelvekin
2
hetrombopag
2
Tretinoin
2
Peripheral Blood Stem Cell Transplantation
2
Filgrastim
2
Cyclophosphamide
2
Carboplatin
2
Busulfan
2
Amplified Fragment Length Polymorphism Analysis
2
sodium thiosulfate
1
siltuximab
1
raltitrexed
1
pegfilgrastim
1
ofatumumab
1
niraparib
1
leridistim
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
apixaban
1
Vorinostat
1
Vitamin B 12
1
Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thrombocytopenia
×
Pharmacokinetics
×
Clear all
NCT04861181
2025-05-22
NIRAPK
Hospices Civils de Lyon
Phase 4
Terminated
12 enrolled